ReShape Lifesciences RSLS
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2024Q2 | 0.19 | 130.66 | -0.07 | -2,054 | -2 | |
| 2024Q1 | 0.18 | 101.01 | -0.09 | -2,210 | -2 | |
| 2023Q4 | 0.25 | 111.93 | 1.54 | -1,895 | -2 | |
| 2023Q3 | 0.34 | 109.88 | -0.97 | -3,880 | -4 | |
| 2023Q2 | 1.48 | 114.91 | -0.92 | -3,977 | -3 | |
| 2023Q1 | 2.57 | 213.05 | -1.56 | -5,631 | -3 | |
| 2022Q4 | 6.74 | 100.82 | -35.11 | -16,693 | -16 | |
| 2022Q3 | 15.02 | 97.66 | -27.42 | -12,346 | -12 | |
| 2022Q2 | 28.84 | 94.27 | -24.50 | -9,662 | -10 | |
| 2022Q1 | 59.00 | 100.32 | -21.87 | -8,400 | -8 | |
| 2021Q4 | 82.00 | 99.99 | -135.47 | -35,557 | -35 | |
| 2021Q3 | 144.00 | -50.00 | -14,984 | -18 | ||
| 2021Q2 | 250.00 | -41.50 | -3,702 | -4 | ||
| 2021Q1 | 53.11 | -62.00 | -2,257 | -5 | ||
| 2020Q4 | 39.11 | -109.00 | -3,204 | -9 | ||
| 2020Q3 | 48.50 | -110.50 | -2,173 | -5 | ||
| 2020Q2 | 104.68 | 44.50 | -2,999 | -4 | ||
| 2020Q1 | 96.59 | -102.00 | -4,081 | -4 | ||
| 2019Q4 | 12.07 | 28874.00 | -3,114 | -25 | ||
| 2019Q3 | 19.59 | 142.50 | -5,618 | -29 |